PL3037529T3
Extended soluble ph20 polypeptides and uses thereof
Abstract
This record has no abstract on file.
Term
3.2 yearsto projected expiry
Projected expiry 9 December 2029, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
62 members in 29 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 20138408 | United States of America | P | |
| 28124009 | United States of America | P | |
| 09804345 | European Patent Office (EPO) | A | |
| 2009006501 | United States of America | W |
Members62
| Document | Office | Kind | |
|---|---|---|---|
| US2010143457A1 | United States of America | A1 | |
| CA2746181A1 | Canada | A1 | |
| CA2915783A1 | Canada | A1 | |
| WO2010077297A1 | World Intellectual Property Organization (WIPO) | A1 | |
| MX2011006110A | Mexico | A | |
| AU2009333918A1 | Australia | A1 | |
| SG172064A1 | Singapore | A1 | |
| IL213150A0 | Israel | A0 | |
| IL213150D0 | Israel | D0 | |
| KR20110099126A | Republic of Korea | A | |
| EP2367936A1 | European Patent Office (EPO) | A1 | |
| CO6341652A2 | Colombia | A2 | |
| CN102307993A | China | A | |
| EA201100908A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2012511327A | Japan | A | |
| US2012213767A1 | United States of America | A1 | |
| NZ593641A | New Zealand | A | |
| AU2013202000A1 | Australia | A1 | |
| US2013101577A9 | United States of America | A9 | |
| CN103205407A | China | A | |
| SG194364A1 | Singapore | A1 | |
| KR20140021046A | Republic of Korea | A | |
| AU2009333918B2 | Australia | B2 | |
| CN102307993B | China | B | |
| JP2014128277A | Japan | A | |
| US8927249B2 | United States of America | B2 | |
| KR101493644B1 | Republic of Korea | B1 | |
| JP5670913B2 | Japan | B2 | |
| IL238669A0 | Israel | A0 | |
| IL238669D0 | Israel | D0 | |
| AU2013202000B2 | Australia | B2 | |
| KR101546563B1 | Republic of Korea | B1 | |
| EA201500485A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EA022752B1 | Eurasian Patent Organization (EAPO) | B1 | |
| EP2367936B1 | European Patent Office (EPO) | B1 | |
| CA2746181C | Canada | C | |
| JP5885765B2 | Japan | B2 | |
| US9284543B2 | United States of America | B2 | |
| CN103205407B | China | B | |
| ES2573462T3 | Spain | T3 | |
| EP3037529A1 | European Patent Office (EPO) | A1 | |
| IL213150A | Israel | A | |
| HK1224330A | Hong Kong, China | A | |
| HK1224330A1 | Hong Kong, China | A1 | |
| IL238669A | Israel | A | |
| ZA201104116B | South Africa | B | |
| EP3037529B1 | European Patent Office (EPO) | B1 | |
| DK3037529T3 | Denmark | T3 | |
| LT3037529T | Lithuania | T | |
| PT3037529T | Portugal | T | |
| TR201906944T4 | Türkiye | T4 | |
| HRP20190766T1 | Croatia | T1 | |
| RS58728B1 | Serbia | B1 | |
| SI3037529T1 | Slovenia | T1 | |
| SMT201900259T1 | San Marino | T1 | |
| HUE043591T2 | Hungary | T2 | |
| PL3037529T3This record | Poland | T3 | |
| ES2724588T3 | Spain | T3 | |
| CA2915783C | Canada | C | |
| CY1121618T1 | Cyprus | T1 | |
| BRPI0922538A2 | Brazil | A2 | |
| EA036569B1 | Eurasian Patent Organization (EAPO) | B1 |
Numbers
- Publication
- 3037529
- Application
- 15200797
Titles2
- English
- EXTENDED SOLUBLE PH20 POLYPEPTIDES AND USES THEREOF
- Polish
- WYDŁUŻONE ROZPUSZCZALNE POLIPEPTYDY PH20 I ICH ZASTOSOWANIA
Classification
- CPC, 29
- C12N9/2474
- C12N9/2408
- C12N15/00
- A61K38/00
- A61K47/60
- A61K47/61
- A61K47/6435
- A61P11/00
- A61P13/08
- A61P17/00
- A61P25/00
- A61P25/16
- A61P25/28
- A61P27/02
- A61P29/00
- A61P3/00
- A61P3/04
- A61P31/00
- A61P31/10
- A61P33/04
- A61P33/06
- A61P35/00
- A61P43/00
- A61P9/00
- A61P9/12
- Y02A50/30
- A61K38/47
- C07K14/47
- C12N15/85
- IPC, 5
- C12N9 26
- A61K38 00
- A61K47 60
- A61K47 61
- A61K47 64